UB ScholarWorks

The Staging Option and Drug Development

Show simple item record

dc.contributor.author Lewis, Neal
dc.contributor.author Enke, David
dc.contributor.author Spurlock, David
dc.date.accessioned 2014-11-12T20:29:12Z
dc.date.available 2014-11-12T20:29:12Z
dc.date.issued 2005-11
dc.identifier.citation Neal Lewis, David Enke, David Spurlock, “The Staging Option and Drug Development” Pharmaceutical Engineering, Vol. 25 No. 6, Nov/Dec 2005 en_US
dc.identifier.uri https://scholarworks.bridgeport.edu/xmlui/handle/123456789/1014
dc.description.abstract This article investigates the staging option to analyze an existing case study that involves the potential licensing of a drug compound that is in development. It demonstrates how options analysis is a useful tool in adding insight to the decision making process when conventional valuation methods are not decisive. en_US
dc.language.iso en_US en_US
dc.publisher International Society for Pharmaceutical Engineering en_US
dc.subject Engineering en_US
dc.subject Pharmaceuticals en_US
dc.subject Drug development en_US
dc.title The Staging Option and Drug Development en_US
dc.type Article en_US
dc.publication.issue 6 en_US
dc.publication.name Pharmaceutical Engineering en_US
dc.publication.volume 25 en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ScholarWorks


Advanced Search

Browse

My Account